The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl) -N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation

Tools

Scott, G.S., Kean, R.B., Mikheeva, T., Fabis, M.J., Mabley, J.G., Szabo, C. and Hooper, D.C. (2004) The Therapeutic Effects of PJ34 [N-(6-Oxo-5,6-dihydrophenanthridin-2-yl) -N,N-dimethylacetamide.HCl], a Selective Inhibitor of Poly(ADP-Ribose) Polymerase, in Experimental Allergic Encephalomyelitis Are Associated with Immunomodulation Journal of pharmacology and experimental therapeutics, 310 . pp. 1053-1061. ISSN 1521-0103

Full text not available from this repository.

Official URL: http://dx.doi.org/10.1124/jpet.103.063214

Item Type:	Article
Additional Information:	The article is freely available via the above url
Subjects:	B000 Health Professions > B200 Pharmacology Toxicology and Pharmacy > B210 Pharmacology and Therapeutics
Identification Number:	doi: 10.1124/jpet.103.063214
Faculties:	Faculty of Science and Engineering > School of Pharmacy and Biomolecular Sciences
ID Code:	809
Deposited By:	editor spbs
Deposited On:	01 Dec 2006
Last Modified:	18 Jun 2010 12:29

Repository Staff Only: item control page